(Q77956042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

[Results of irradiation of inoperable stage III non-small cell lung cancer with 25Gy in five fractions] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

S Appold

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Baumann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Neidt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Herrmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

267-270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10392167%20AND%20SRC:MED&resulttype=core&format=json

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Wor

9 December 2019

cites work

1 reference

12 December 2020

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.

1 reference

12 December 2020

Potential pitfalls in the use of p-values and in interpretation of significance levels

1 reference

12 December 2020

Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules

1 reference

12 December 2020

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

12 December 2020

Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung

1 reference

12 December 2020

Inoperable non-small cell lung cancer: a retrospective analysis of 427 patients treated with high-dose radiotherapy

1 reference

12 December 2020

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

12 December 2020

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions

1 reference

12 December 2020